Physician profile
Alexander Gershman
NPI 1124058219
$6,598.56
in general payments reported to CMS, 2019-2025
43 companies · $684 in 2025
The $684 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,182 · 2020: $746 · 2021: $895 · 2022: $1,199 · 2023: $770 · 2024: $1,123 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,576.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $908.31 | 2019-2025 | Rezum Generator, Ams 700, Solyx Sis System |
| Astellas Pharma US INC | $817.18 | 2019-2024 | Veozah |
| Sumitomo Pharma America, INC. | $562.20 | 2023-2025 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $542.22 | 2019-2025 | Provenge |
| Pfizer INC. | $532.35 | 2019-2025 | |
| Amgen INC. | $509.86 | 2019-2022 | |
| Teleflex LLC | $237.43 | 2021-2024 | Solesta |
| Coloplast Corp | $215.94 | 2021-2025 | Titan, Speedicath |
| Urovant Sciences INC | $210.28 | 2022 | |
| Endo Pharmaceuticals INC. | $186.64 | 2019-2024 | Xiaflex |
| Allergan, INC. | $165.70 | 2019 | |
| Telix Pharmaceuticals | $150.52 | 2025 | Illuccix |
| Acerus Pharmaceuticals Corporation | $133.67 | 2020-2022 | |
| Immunitybio, INC. | $126.37 | 2025 | |
| Myriad Genetic Laboratories, INC. | $122.05 | 2021-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $120.81 | 2019-2025 | Adstiladrin |
| Urogen Pharma, INC. | $118.47 | 2023-2024 | Jelmyto |
| Profound Medical Corp. | $89.59 | 2022 | |
| Myovant Sciences INC. | $83.95 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $76.87 | 2021-2024 | Pylarify |
| Takeda Pharmaceuticals U.S.A., INC. | $66.19 | 2019 | |
| Abbvie INC. | $62.05 | 2023-2025 | |
| Amag Pharmaceuticals, INC. | $46.77 | 2019 | |
| Ethicon US, LLC | $46.25 | 2020-2021 | |
| Novo Nordisk INC | $40.75 | 2023-2024 | Wegovy |
| Janssen Biotech, INC. | $38.08 | 2025 | Erleada |
| Baxter Healthcare | $33.58 | 2020 | |
| Metuchen Pharmaceuticals | $32.70 | 2019-2020 | |
| Intuitive Surgical, INC. | $31.76 | 2022 | |
| Horizon Therapeutics Plc | $26.78 | 2022 | |
| Axonics, INC. | $25.72 | 2022 | |
| 180 Medical, INC. | $25.30 | 2023 | |
| Agiliti Surgical, INC. | $25.16 | 2025 | Koelis Trinity Mri/US Fusion, Olympus Soltive Tfl Laser, Sonablate Hifu |
| Hikma Pharmaceuticals USA | $24.46 | 2020-2021 | |
| C. R. Bard, INC. & Subsidiaries | $23.99 | 2023 | Bard Urinary Drainage Bag |
| Avadel Specialty Pharmaceuticals, LLC | $22.06 | 2019 | |
| Merck Sharp & Dohme LLC | $19.04 | 2022 | |
| Laborie Medical Technologies Corp. | $18.86 | 2020 | |
| Uroviu Corporation | $18.81 | 2023 | Uro-G Flexible Cystoscope |
| Calyxo, INC. | $17.75 | 2024 | Cvac Aspiration System |
| Accord Healthcare, INC. | $15.41 | 2024 | |
| Hollister Incorporated | $14.34 | 2019 | |
| Mission Pharmacal Company | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Gershman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.